Merus (MRUS) CEO Lundberg disposed of 83,435 shares at $97.00
Insider transactions reported
Sven Ante Lundberg (President, CEO & PEO at Merus N.V., MRUS) reported that they disposed of 83,435 shares at $97.00 on Dec 12, 2025. After these transactions the filing shows 0 shares held indirectly (Ante S Lundberg Qualified Annuity Interest Trust XI) and 0 shares held indirectly (Ante S Lundberg Qualified Annuity Int Trust X).
- Reporting person
- Lundberg Sven Ante
- Role
- President, CEO & PEO
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Dec 12, 2025 | Tender of shares in a change of control (U) | Common Shares1, 2 | -30,297 | $97.00 | $2.94M | 0 indirect |
| Dec 12, 2025 | Tender of shares in a change of control (U) | Common Shares1, 2 | -16,372 | $97.00 | $1.59M | 0 indirect |
| Dec 12, 2025 | Tender of shares in a change of control (U) | Common Shares1, 2 | -9,191 | $97.00 | $892K | 0 indirect |
| Dec 12, 2025 | Tender of shares in a change of control (U) | Common Shares1, 2 | -9,191 | $97.00 | $892K | 0 indirect |
| Dec 12, 2025 | Tender of shares in a change of control (U) | Common Shares1, 2 | -9,192 | $97.00 | $892K | 0 indirect |
| Dec 12, 2025 | Tender of shares in a change of control (U) | Common Shares1, 2 | -9,192 | $97.00 | $892K | 0 indirect |
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Dec 12, 2025 | Sale back to the company (D) | Share Option (right to buy)On 1,999,248 Common Shares3 | -1,999,248 | - | - | 0 direct |
Holdings before and after
- Common Shares: 30,297 to 0 indirect, Ante S Lundberg Qualified Annuity Interest Trust XI
- Common Shares: 16,372 to 0 indirect, Ante S Lundberg Qualified Annuity Int Trust X
- Common Shares: 9,191 to 0 indirect, Katrina Lundberg 2018 Irrevocable Trust
- Common Shares: 9,191 to 0 indirect, Madeleine Lundberg 2018 Irrevocable Trust
- Common Shares: 9,192 to 0 indirect, Kristian Ante Lundberg 2018 Irrevocable Trust
- Common Shares: 9,192 to 0 indirect, Emily Lundberg 2018 Irrevocable Trust
- Share Option (right to buy): 312,620 to 0 direct
Footnotes from the filing
- 1. On September 29, 2025, Merus N.V. (the Issuer ) entered into a transaction agreement (as it may be amended, supplemented or otherwise modified from time to time, the Transaction Agreement ) with Genmab A/S ( Genmab ) and its wholly owned subsidiary, Genmab Holding II B.V. (the Purchaser ). Pursuant to the terms of the Transaction Agreement, the Purchaser commenced a tender offer for all the issued and outstanding common shares, par value EUR 0.09 per share (the Shares ), of the Issuer (the Offer ), and, on December 12, 2025 (the Acceptance Time ), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer as of the Acceptance Time, including the Shares tendered by the reporting person, in exchange for a cash payment equal to $97.00 per Share, without interest and less applicable withholding taxes (the Offer Consideration ), which Offer Consideration will be paid as soon as practicable following the Acceptance Time.
- 2. The indirect holdings represent shares for which the Reporting Person and members of his immediate family are the sole beneficiaries.
- 3. This option was cancelled pursuant to the Transaction Agreement in exchange for cash (without interest and net of applicable withholding tax and other applicable deductions) in an amount equal to the product of (i) the amount by which the Offer Consideration exceeds the applicable exercise price per Share of such option and (ii) the aggregate number of Shares underlying such option.
FAQ
What did Lundberg report in this MRUS Form 4?
Sven Ante Lundberg (President, CEO & PEO at Merus N.V., MRUS) reported that they disposed of 83,435 shares at $97.00 on Dec 12, 2025. After these transactions the filing shows 0 shares held indirectly (Ante S Lundberg Qualified Annuity Interest Trust XI) and 0 shares held indirectly (Ante S Lundberg Qualified Annuity Int Trust X).
How many MRUS shares does Lundberg hold after this filing?
The filing shows 0 shares held indirectly (Ante S Lundberg Qualified Annuity Interest Trust XI), 0 shares held indirectly (Ante S Lundberg Qualified Annuity Int Trust X), 0 shares held indirectly (Katrina Lundberg 2018 Irrevocable Trust) after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
Historical context for MRUS
Earlier insider filings at MRUS
- Dec 12, 2025SEC Form 4 filed by Director Pucci Paolo
- Dec 12, 2025VP Controller, PAO Shuman Harry closing all direct ownership in the company (SEC Form 4)
- Dec 12, 2025SEC Form 4 filed by Director Sandor Victor
- Dec 12, 2025Director Iwicki Mark T closing all direct ownership in the company (SEC Form 4)
- Dec 12, 2025SEC Form 4 filed by Director Gowen Maxine
Keep researching MRUS
- MRUS insider tradesEvery buy and sale reported by Merus N.V. officers, directors and large holders.
- What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2016
Follow MRUS and get a push notification the moment its next story breaks.